Riskpilot← Back to searchSign inGet full accessLILLE GRENSEN LEGESENTER AS
ASActiveOrg 983801552Lille Grensen 3, 0159 OsloGeneral medical practice activities · NACE 8621Est. 20017 employees
Revenue 2024
NOK 6,8M
+41% vs 2023
EBITDA margin
-7.2%
-4255% vs 2023
Equity ratio
-8.8%
Financial strength
Net profit 2024
NOK -655K
-1075% vs 2023
| Revenue | NOK 6,8M | +41% |
| EBITDA | NOK -486K | -4255% |
| Net profit | NOK -655K | -1075% |
| Total assets | NOK 2,6M | +178% |
| Equity | NOK -227K | -153% |
| Employees | 7 | — |
Legal name
LILLE GRENSEN LEGESENTER AS
Org number
983801552
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
16. oktober 2001
Share capital
NOK 300 000
Employees
7 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Drift av legesenter, ytelse av helsetjenester, forskning, informasjon og konsulentvirksomhet.
Address
Lille Grensen 3, 0159 Oslo
Phone
+4723104020
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 4 122 | 4 406 | 4 875 | 4 813 | 6 779 |
| Staff expenses | −1 609 | −1 726 | −2 130 | −2 133 | −2 749 |
| EBITDA | 198 | 246 | 231 | 12 | −486 |
| Depreciation & amort. | −19 | −31 | −51 | −61 | −110 |
| EBIT | 179 | 215 | 180 | −49 | −596 |
| Net financials | −1 | −12 | −12 | −12 | −59 |
| Profit before tax | 178 | 203 | 169 | −61 | −655 |
| Tax | 40 | 45 | 43 | −6 | −0 |
| Net profit | 138 | 158 | 126 | −56 | −655 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 783 | 952 | 992 | 924 | 2 570 |
| Equity | 201 | 358 | 484 | 429 | −227 |
| Long-term debt | 0 | 0 | 6 | 0 | 1 900 |
| Short-term debt | 582 | 593 | 503 | 496 | 897 |
| Total debt | 582 | 593 | 508 | 496 | 2 797 |
EBITDA margin
-7.2%
This company
15.8%
Market median
-146% vs market
20202024
Equity ratio
-8.8%
This company
38.2%
Market median
-123% vs market
20202024
Return on equity
-65521700.0%
This company
18.4%
Market median
-356096296% vs market
20202024
Net profit margin
-9.7%
This company
8.1%
Market median
-220% vs market
20202024
Asset turnover
2.64×
This company
1.12×
Market median
+136% vs market
20202024
Debt / equity
12.34×
This company
0.62×
Market median
-1890% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AF Chief Executive Officer | Chief Executive Officer | 2017 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Board of Directors | 2017 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 25% | 25% | 2022 | |
| Company | 12.67% | 12.67% | 2022 | |
| Individual | 12.33% | 12.33% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of LILLE GRENSEN LEGESENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anders Faaberg | Chief Executive Officer | 0 companies |
| Geir Sneen | Chairman | 0 companies |
| Aslak Holtestaul | Board of Directors | 0 companies |
| Sebastian Doricic | Board of Directors | 0 companies |
| Trond Daae-Johansen | Board of Directors | 0 companies |